CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- 4 Planned sale General Counsel sold 1,799 shares at $44.26 ($79,624)
- 4 Planned sale Chief Medical Officer sold 2,160 shares at $45.82 ($98,982)
- 4 Planned sale Kelsey Stephen Michael sold 5,367 shares at $45.82 ($245,942)
- 4 Planned sale GOLDSMITH MARK A sold 13,411 shares at $45.82 ($614,558)
- 4 Planned sale Chief Operating Officer sold 4,775 shares at $45.82 ($218,814)
- 4 Planned sale General Counsel sold 1,869 shares at $45.82 ($85,647)
- 4 Planned sale Chief Financial Officer sold 2,320 shares at $45.82 ($106,314)
- 4 Planned sale Kelsey Stephen Michael sold 125,000 shares at an average $44.46 ($5,557,754)
- 4 Planned sale Chief Financial Officer sold 10,000 shares at an average $40.10 ($400,992)
- 4 Exercise or conversion GOLDSMITH MARK A acquired 37,000 shares (option exercise)
- 4 Grant or award Director acquired 3,142 shares (grant or award)
- 4 Grant or award Director acquired 3,142 shares (grant or award)
- 4 Grant or award Director acquired 3,142 shares (grant or award)
- 4 Grant or award Director acquired 3,142 shares (grant or award)
- 4 Grant or award Director acquired 3,142 shares (grant or award)
- 4 Grant or award Director acquired 3,142 shares (grant or award)
- 4 Grant or award Director acquired 2,806 shares (grant or award)
- 4 Planned sale General Counsel sold 1,912 shares at $39.61 ($75,736)
- 4 Planned sale Chief Operating Officer sold 3,510 shares at $39.83 ($139,803)
- 4 Planned sale GOLDSMITH MARK A sold 13,496 shares at $39.83 ($537,546)
Page 5 of 21 · 414 filings